Cord Blood Day One

 

Cord Blood Day 1- Wednesday 16th May 2018

08:00

08:00 Registration opens

Opening Keynotes: Innovative Applications of Cord Blood

Cord Blood Plenary
08:50

Welcome from Terrapinn

Cord Blood Plenary
09:00

Evaluating the efficacy of umbilical cord blood to improve outcomes for children with Autism

  •     An update from Joanne’s latest clinical trials
  •     Umbilical cord blood-derived cell therapies may have potential in alleviating ASD symptoms by modulating inflammatory processes in the brain
  •     Looking to the future of cord blood clinical use
     
Cord Blood Plenary
09:25

Intravenous infusion of umbilical cord tissue (UC) derived Mesenchymal Stem Cells (MSCs) versus bone marrow (BM) derived MSCs to evaluate cytokine suppression in Patients with chronic inflammation due

  • A Phase I/II, Randomized, Placebo-controlled Comparative Study to compare Umbilical Cord Tissue (UC) Derived Mesenchymal Stem Cells (MSCs) Versus Bone Marrow (BM) Derived MSCs
 
Cord Blood Plenary
09:50

Off-the-shelf CAR-engineered cord blood derived natural killer cells to treat cancer

  • Discuss approaches for the GMP grade expansion of cord blood derived natural killer cells for cellular therapy
  • Discuss strategies to engineer cord blood derived natural killer cells to enhance their anti-tumor potency and in vivo persistence
  • Present data on the first-in-human clinical trial of off-the-shelf CAR-engineered cord blood derived natural killer cells
 
10:40

Networking Refreshment Break

Cord Blood Plenary
11:40

Round table session

13:00

Networking Lunch

Collection, Bioprocessing and Storage

Cord Blood Plenary
15:10

An effective logistical case study for stem cell collection, storage and use in Thailand

  •     The challenges of storing, collecting and processing stem cells in South East Asia
  •     Overview of processes and how challenges can be overcome
  •     Successful case studies
Cord Blood Plenary
15:30

Timing of cord clamping and impact on cord blood collection

  •     Delayed clamping of the umbilical cord after birth has been a subject of controversy and debate
  •     Overview of evidence 
  •     Suggested Industry responsibility and actions 
15:50

Networking Refreshment Break

Expansion and Engraftment

Cord Blood Plenary
16:30

The safety and efficacy of human placental derived stem cells in combination with unrelated cord blood transplantation in children

  • Background on UCBT and HPDSC
  • Hematopoietic engraftment following UCBT & HPDSC
  • Immune Reconstitution following UCBT & HPDSC
  • Probability of Acute and Chronic GVHD following UCBT & HPDSC
Cord Blood Plenary
16:50

The science behind ex vivo manipulation of CB HSCs for transplantation

  •     A consultant haematologist at UCLH and a Senior Lecturer at the UCL Cancer institute: his interests include understanding cell fate choices in haematopoietic stem cells
  •     Rajeev Gupta is currently carrying out some fascinating work encompassing pre-treating CB HSCs with various techniques, and studying those effects on engraftment 
Cord Blood Plenary
17:10

Ex vivo expansion of cord blood hematopoietic stem cells - from formulation to manufacturing process CombiCult- combinatorial cell culture as a platform to find optimal media compositions for the stem

  • Application of CombiCult for HSC expansion
  • Identification of media formulations that enrich the HSC compartment
  • In vitro analysis of expanded cells
  • Identification of GMP-compliant processes for HSC cell expansion
18:15

Offsite Networking Drinks

last published: 14/May/18 16:05 GMT

 

DOWNLOAD BROCHURE

 

 

 

TO SPONSOR / EXHIBIT

Erica Baeta
+44 (0)207 092 1152
erica.baeta@terrapinn.com

TO SPEAK

Jessica Robinson
t/ +44 (0)207 092 1150
jessica.robinson@terrapinn.com

TO REGISTER

Issa Mauthoor
+44 (0)207 092 1257
issa.mauthoor@terrapinn.com